Real-time navigation system for sentinel lymph node biopsy in breast cancer patients using projection mapping with indocyanine green fluorescence

• Published in: Breast cancer (Tokyo, Japan) Japan), 2018-11, Vol.25 (6), p.650-655
• Main Authors: Takada, Masahiro, Takeuchi, Megumi, Suzuki, Eiji, Sato, Fumiaki, Matsumoto, Yoshiaki, Torii, Masae, Kawaguchi-Sakita, Nobuko, Nishino, Hiroto, Seo, Satoru, Hatano, Etsuro, Toi, Masakazu
• Format: Article
• Language: English
• Subjects: Adult; Aged; Breast cancer; Breast Neoplasms - diagnostic imaging; Cancer; Cancer patients; Cancer Research; Care and treatment; Electronics in navigation; Female; Fluorescence; Humans; Image-Guided Biopsy - methods; Indocyanine Green; Lymphatic Metastasis - diagnostic imaging; Medical imaging equipment; Medicine; Medicine & Public Health; Middle Aged; Oncology; Oncology, Experimental; Original Article; Predictive Value of Tests; Sentinel Lymph Node Biopsy - methods; Surgery; Surgical Oncology
• ISSN: 1340-6868; 1880-4233
• DOI: 10.1007/s12282-018-0868-2

Background Inability to visualize indocyanine green fluorescence images in the surgical field limits the application of current near-infrared fluorescence imaging (NIR) systems for real-time navigation during sentinel lymph node (SLN) biopsy in breast cancer patients. The aim of this study was to evaluate the usefulness of the Medical Imaging Projection System (MIPS), which uses active projection mapping, for SLN biopsy. Methods A total of 56 patients (59 procedures) underwent SLN biopsy using the MIPS between March 2016 and November 2017. After SLN biopsy using the MIPS, residual SLNs were removed using a conventional NIR camera and/or radioisotope method. The primary endpoint of this study was identification rate of SLNs using the MIPS. Results In all procedures, at least one SLN was detected by the MIPS, giving an SLN identification rate of 100% [95% confidence interval (CI) 94–100%]. SLN biopsy was successfully performed without operating lights in all procedures. In total, 3 positive SLNs were excised using MIPS, but were not included in the additional SLNs excised by other methods. The median number of SLNs excised using the MIPS was 3 (range 1–7). Of procedures performed after preoperative systemic therapy, the median number of SLNs excised using the MIPS was 3 (range 2–6). Conclusions The MIPS is effective in detecting SLNs in patients with breast cancer, providing continuous and accurate projection of fluorescence signals in the surgical field, without need for operating lights, and could be useful in real-time navigation surgery for SLN biopsy.